We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. serves customers who are accelerating life sciences research, solving complex analytica... read more Featured Products: More products

Download Mobile App




Glycated Albumin Is a Promising Marker for Diabetes

By LabMedica International staff writers
Posted on 30 Nov 2015
Although glucose level is the contributing factor and diagnostic marker for type 2 diabetes, there is an imperative need to look “beyond glucose” and to seek additional biomarkers that could better predict the risk for diabetes as well its diagnosis with accurate precision. More...


Human serum albumin is one of the most abundant plasma proteins that readily undergoes glycation, thus glycated albumin has been suggested as an additional marker for monitoring glycemic status in people with type 2 diabetes.

Scientists at the National Chemical Laboratory (Pune, India) collected blood samples from a diabetes specialized clinic as well as healthy controls. Diagnostic parameters, including fasting blood glucose, HbA1c, oral glucose tolerance test, postprandial blood sugar, lipids, urea, creatinine, and microalbumin were measured. Equal volumes of two plasma samples with similar HbA1c (deviation of less than 0.2%) were pooled, and three such pooled plasma in each group were used for mass spectrometric technical triplicate analysis.

The team used high resolution accurate mass spectrometry (HR/AM) which has paved the way for the fragment ion library that was used for quantification of glycated peptides of albumin in the context of diabetes. Glycation is a non-enzymatic chemical reaction between glucose and proteins leading to formation of advanced glycation end products (AGEs), which have been implicated in the pathogenesis of type 2 diabetes and its complications. All samples were analyzed on hybrid quadruple Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Scientific; Waltham, MA, USA).

Muthuswamy Balasubramanyam, PhD, senior author of the study said, “While earlier studies quantified only Amadori-modified lysine (AML) modifications, our study in addition characterized the carboxymethyl-lysine (CML) and carboxyethyl-lysine (CEL) modified peptides of albumin and this is an important advancement as CML and CEL are the predominant AGEs, constituting up to 80% of total AGEs. The association of CML modified peptides of albumin with prediabetes, diabetes, and microalbuminuria is a clinically relevant and therapeutically important finding.” The study was published originally online on August 1, 2015, in the journal Molecular Cell Proteomics.

Related Links:

National Chemical Laboratory 
Thermo Scientific 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.